Literature DB >> 1499733

Is the cytosolic catalase induced by peroxisome proliferators in mouse liver on its way to the peroxisomes?

A M Eriksson1, B Lundgren, K Andersson, J W DePierre.   

Abstract

Dietary treatment of male C57B1/6 mice with clofibrate, nafenopin or WY-14.643 resulted in a modest (at most 2-fold) increase in the total catalase activity in the whole homogenate and mitochondrial fraction prepared from the livers of these animals. On the other hand, the catalase activity recovered in the cytosolic fraction was increased 12- to 18-fold, i.e. 30-35% of the total catalase activity in the hepatic homogenate was present in the high-speed supernatant fraction after treatment with these peroxisome proliferators. A study of the time course of the changes in peroxisomal and cytosolic catalase activities demonstrated that the peroxisomal activity both increased upon initiation of exposure and decreased after termination of treatment several days after the increase and decrease, respectively, in the corresponding cytosolic activity. This finding suggests that the cytosolic catalase may be on its way to incorporation into peroxisomes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499733     DOI: 10.1016/0014-5793(92)81276-r

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Regulation of catalase enzyme activity by cell signaling molecules.

Authors:  Sumio Yano; Noriko Yano
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

Review 2.  Catalase and nonalcoholic fatty liver disease.

Authors:  Su-Kyung Shin; Hyun-Woo Cho; Seung-Eun Song; Dae-Kyu Song
Journal:  Pflugers Arch       Date:  2018-08-17       Impact factor: 3.657

3.  Effects of an early life diet containing large phospholipid-coated lipid globules on hepatic lipid metabolism in mice.

Authors:  Onne A H O Ronda; Bert J M van de Heijning; Ingrid Martini; Albert Gerding; Justina C Wolters; Ydwine T van der Veen; Martijn Koehorst; Angelika Jurdzinski; Rick Havinga; Eline M van der Beek; Folkert Kuipers; Henkjan J Verkade
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.